A comparison between the administration of oral prolonged-release oxycodone-naloxone and transdermal fentanyl in patients with moderate-to-severe cancer pain: a propensity score analysis

BACKGROUND: Opioids are the most important pharmacological treatment for moderate-to-severe cancer pain, but side effects limit their use. Transdermal fentanyl (TDF) and oral prolonged-release oxycodone-naloxone (OXN-PR) are effective in controlling chronic pain, with less constipation compared to o...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Pain Res
Autors principals: Roberto, A, Greco, MT, Legramandi, L, Galli, F, Galli, M, Corli, O
Format: Artigo
Idioma:Inglês
Publicat: Dove Medical Press 2017
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5590764/
https://ncbi.nlm.nih.gov/pubmed/28919810
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JPR.S141928
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars